Back to Business

Pulmovant to present phase 2 mosliciguat study results Tuesday

Business September 6, 2026 at 5:04 AM

Pulmovant to present phase 2 mosliciguat study results Tuesday

Investing.com

Read at Investing.com

More Stories

SEC seeks court order forcing ISS to hand over client voting data

SEC seeks court order forcing ISS to hand over client voting data

🇺🇸 Investing.com 44m ago

Roivant to present phase 2 pulmonary hypertension study results

Roivant to present phase 2 pulmonary hypertension study results

🇺🇸 Investing.com 1h ago

Investors turn to Chinese stocks as alternative to crowded AI trades

Investors turn to Chinese stocks as alternative to crowded AI trades

🇺🇸 Investing.com 1h ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play